A new software package called CREsted, published in Nature Methods, gives researchers an end-to-end workflow for modeling and ...

With two decades of dedicated focus in this field, Cloud-Clone has evolved from early-stage exploration into a globally ...

Endotoxin-free proteins provide a more reliable choice for preclinical research, precise cellular experiments, and ...

Scientists report lab evidence that a single PFAS, PFDA, shows the strongest developmental toxicity signal to date, raising ...

CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), today announces a new payer coverage agreement with Highmark, effective April 1, ...

Integrating Digital Holographic Microscopy with fluorescence techniques enhances live-cell imaging, preserving cellular ...

Performance driven by core drug discovery, continued adoption in environmental toxicology, and launch of new assays and ...

The FDA has delayed its target decision date for Orca Bio’s blood cancer cell therapy candidate Orca-T by three months to ...

Symeres has entered a collaboration with Ambagon Therapeutics on molecular glue research in colorectal cancer, aiming to ...

Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, today ann ...

Semarion has secured new funding to expand its cell-based drug discovery platform, supporting manufacturing scale-up, ...

The field of genetics is advancing through rapid improvements in genomic assays, analysis methods, functional validation, and clinical and agricultural ...